OMENTIN METABOLISM AND PATHOPHYSIOLOGICAL RELATIONSHIP BETWEEN ITS LEVEL AND THE SEVERITY OF LESIONS IN THE INTIMA-MEDIA THICKNESS OF THE CAROTID ARTERIES IN TYPE 2 DIABETES MELLITUS IN COMBINATION WITH OBESITY
Abstract
The relationship of visceral obesity and excess body weight (EBW) with the development of cardiovascular diseases, type 2 diabetes mellitus (DM) and effect on quality and duration of life determine the relevance of studying this problem.
The aim: to assess omentin-1 metabolism and pathophysiological relationship between its level and the severity of lesions in the intima-media thickness (IMT) of the carotid arteries in type 2 DM in combination with EBW and obesity.
Materials and methods. We examined 98 people with DM, the first group consisted of 64 people with EBW and obesity, second group consisted of 34 people with normal body weight, control group – 28 healthy individuals. The concentration of omentin-1 was investigated by ELISA by solid-phase enzyme-linked immunosorbent assay in vitro. Ultrasound of the carotid arteries was performed in the lying position of the patient on the device MyLab50X with a linear sensor of 7 MHz with a slight deviation of the patient's head in the opposite direction.
Results. Evaluation of the correlation matrix showed the presence of a positive rather strong negative connection between IMT, especially the right carotid artery and the level of omentin-1 in the blood (Rs = –0.55; p = 0.002). The largest number of individuals with omentin-1 levels from 5–10 ng / ml had significant disorders of the vascular wall (IMT from 1.0 to 1.2 mm).
Conclusion. Obtained data indicate a statistically significant associative relationship between the dynamics of the predictor of cardiovascular risk – IMT with the degree of impaired expression of omentin-1.
Downloads
References
Ohashi, K., Shibata, R., Murohara, T., Ouchi, N. (2014). Role of anti-inflammatory adipokines in obesity-related diseases. Trends in Endocrinology & Metabolism, 25 (7), 348–355. doi: https://doi.org/10.1016/j.tem.2014.03.009
Ghoorah, K., Campbell, P., Kent, A., Maznyczka, A., Kunadian, V. (2014). Obesity and cardiovascular outcomes: a review. European Heart Journal: Acute Cardiovascular Care, 5 (1), 77–85. doi: https://doi.org/10.1177/2048872614523349
Varona, J. F., Ortiz-Regalón, R., Sánchez-Vera, I., López-Melgar, B., García-Durango, C., Castellano Vázquez, J. M. et. al. (2019). Soluble ICAM 1 and VCAM 1 Blood Levels Alert on Subclinical Atherosclerosis in Non Smokers with Asymptomatic Metabolic Syndrome. Archives of Medical Research, 50 (2), 20–28. doi: https://doi.org/10.1016/j.arcmed.2019.05.003
Sengul, E., Duygulu, G., Dindar, S., Bunul, F. (2013). Serum omentin-1, inflammation and carotid atherosclerosis in patients with non-diabetic chronic kidney disease. Renal Failure, 35 (8), 1089–1093. doi: https://doi.org/10.3109/0886022x.2013.817256
Yasir, M., Senthilkumar, G. P., Jayashree, K., Ramesh Babu, K., Vadivelan, M., Palanivel, C. (2019). Association of serum omentin-1, apelin and chemerin concentrations with the presence and severity of diabetic retinopathy in type 2 diabetes mellitus patients. Archives of Physiology and Biochemistry, 1–8. doi: https://doi.org/10.1080/13813455.2019.1680698
Yoo, H., Hwang, S., Hong, H., Choi, H., Yang, S., Seo, J. A. et. al. (2011). Association of circulating omentin-1 level with arterial stiffness and carotid plaque in type 2 diabetes. Cardiovascular Diabetology, 10 (1), 103. doi: https://doi.org/10.1186/1475-2840-10-103
Bohula, E. A., Scirica, B. M., Inzucchi, S. E., McGuire, D. K., Keech, A. C., Smith, S. R. et. al. (2018). Effect of lorcaserin on prevention and remission of type 2 diabetes in overweight and obese patients (CAMELLIA-TIMI 61): a randomised, placebo-controlled trial. The Lancet, 392 (10161), 2269–2279. doi: https://doi.org/10.1016/s0140-6736(18)32328-6
Vedal, T. S. J., Steen, N. E., Birkeland, K. I., Dieset, I., Reponen, E. J., Laskemoen, J. F. et. al. (2019). Adipokine levels are associated with insulin resistance in antipsychotics users independently of BMI. Psychoneuroendocrinology, 103, 87–95. doi: https://doi.org/10.1016/j.psyneuen.2019.01.001
Hayashi, M., Morioka, T., Hatamori, M., Kakutani, Y., Yamazaki, Y., Kurajoh, M. et. al. (2019). Plasma omentin levels are associated with vascular endothelial function in patients with type 2 diabetes at elevated cardiovascular risk. Diabetes Research and Clinical Practice, 148, 160–168. doi: https://doi.org/10.1016/j.diabres.2019.01.009
Nezu, T., Hosomi, N., Aoki, S., Matsumoto, M. (2016). Carotid Intima-Media Thickness for Atherosclerosis. Journal of Atherosclerosis and Thrombosis, 23 (1), 18–31. doi: https://doi.org/10.5551/jat.31989
Copyright (c) 2020 Roman Kulynych, Olena Soloviuk , Oleksandr Soloviuk
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our journal abides by the CREATIVE COMMONS copyright rights and permissions for open access journals.
Authors, who are published in this journal, agree to the following conditions:
1. The authors reserve the right to authorship of the work and pass the first publication right of this work to the journal under the terms of a Creative Commons Attribution License, which allows others to freely distribute the published research with the obligatory reference to the authors of the original work and the first publication of the work in this journal.
2. The authors have the right to conclude separate supplement agreements that relate to non-exclusive work distribution in the form in which it has been published by the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.
